Heparin, escin and essential phospholipids gel as part of complex therapy in the early postoperative period in patients with lower limb varicose vein disease
https://doi.org/10.21518/akh2025-026
Abstract
Introduction. Chronic venous diseases of the lower extremities represent a common medical issue significantly impacting patients’ quality of life. Particular attention is paid to optimizing the postoperative period in the treatment of varicose veins.
Aim. The study aimed to evaluate the effect of local application of gel based on heparin, escin and essential phospholipids on reducing pain, edema, and accelerating hematoma resolution in the early postoperative period in patients undergoing radiofrequency ablation combined with miniphlebectomy.
Materials and methods. A prospective randomized controlled trial was conducted involving 60 patients divided into two groups: control (30 patients) and experimental (30 patients). Pain levels, edema dynamics, hematoma size, and quality of life were assessed.
Results. The use of gel based on heparin, escin and essential phospholipids contributed to faster pain reduction (statistically significant differences from day 3), edema reduction (from day 3), and hematoma resolution (complete disappearance by day 14 in the experimental group). No statistically significant differences in quality of life between groups were observed one month after surgery.
Discussion. The findings confirm the efficacy of gel based on heparin, escin and essential phospholipids in improving early postoperative outcomes due to its anti-inflammatory, anti-edema, and regenerative effects.
Conclusions. Gel based on heparin, escin and essential phospholipids can be recommended as an adjunct to standard postoperative care to enhance patient comfort during the early postoperative period in the treatment of varicose veins of the lower extremities.
About the Authors
A. A. SeninRussian Federation
Andrey A. Senin, Surgeon, Phlebologist,
46, Komsomolskaya St., Saratov, 410031
V. A. Gavrilov
Russian Federation
Vladimir A. Gavrilov, Cand. Sci. (Med.), Professor RAE, Surgeon, Leading Phlebologist,
46, Komsomolskaya St., Saratov, 410031,
F. K. Ablyayev
Russian Federation
Farit K. Ablyayev, Surgeon, Phlebologist,
46, Komsomolskaya St., Saratov, 410031
References
1. Setia A, Schmedt CG, Sroka R. Endovenous laser ablation using laser systems emitting at wavelengths>1900 nm: a systematic review. Lasers Med Sci. 2022;37(9);3473–3483. https://doi.org/10.1007/s10103-022-03609-w.
2. Attaran RR, Carr JG. Chronic Venous Disease of the Lower Extremities: A State-of-the Art Review. J Soc Cardiovasc Angiogr Interv. 2022;2(1):100538. https://doi.org/10.1016/j.jscai.2022.100538.
3. Raffetto JD, Khalil RA. Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins. Vessel Plus. 2021;5:36. https://doi.org/10.20517/2574-1209.2021.16.
4. Beregovykh R, Prozherina Yu. Chronic vein diseases: a pressing issue of our time. Remedium. 2019;(11):27–31. (In Russ.) https://doi.org/10.21518/1561-5936-2019-11-27-31.
5. Anuforo A, Evbayekha E, Agwuegbo C, Okafor TL, Antia A, Adabale O et al. Superficial Venous Disease-An Updated Review. Ann Vasc Surg. 2024;105;106–124. https://doi.org/10.1016/j.avsg.2024.01.009.
6. Sukovatykh BS, Sereditsky AV, Sukovatykh MB, Rodionov OA. Efficacy of Detragel in treatment of varicothrombophlebitis in elderly and aged patients. Angiology and Vascular Surgery. 2020;26(1):69–73. (In Russ.) Available at: https://www.angiol.ru/patrns/pdf/2020/angiol-2020-1.pdf.
7. Kamaev AA, Bulatov VL, Vakhratyan PE, Volkov AM, Volkov AS, Gavrilov EK et al. Varicose veins. Flebologiya. 2022;16(1):41–108. (In Russ.) https://doi.org/10.17116/flebo20221601141.
8. Galanaud J, Genty С, Sevestre М, Brisot D, Lausecker M, Gillet JL et al. Predictive factors for concurrent deepvein thrombosis and symp tomatic venous thromboembolic recurrence in case of superficial venous thrombolisis: The OPTIMEV study. Thromb Haemost. 2011;105(1):31–39. https://doi.org/10.1160/TH10-06-0406.
9. Ruggiero M, Grande R, Naso A, Butrico L, Rubino P, Placida GD et al. Symptoms in patients with skin changes due to chronic venous insufficiency often lead to emergency care service: an Italian observational study. Int Wound J. 2016;13(5):967–971. https://doi.org/10.1111/iwj.12498.
10. Ortega MA, Fraile-Martínez O, García-Montero C, Álvarez-Mon MA, Chaowen C, Ruiz-Grande F et al. Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management. J Clin Med. 2021;10(15):3239. https://doi.org/10.3390/jcm10153239.
11. Yun S, Hwang M. Size Matters for the Treatment of Varicose Veins. Ann Phlebology. 2024;22(1):9–13. https://doi.org/10.37923/phle.2024.22.1.9.
12. Raskin VV, Semenov AYu, Kurginyan KhM. Endovenous laser obliteration in the prevention of relapse of varicose veins in the anterior saphenous vein pool. Profilakticheskaya Meditsina. 2020;23(3):98–103. (In Russ.) https://doi.org/10.17116/profmed20202303198.
13. Soboleva PYu, Gaboyan AS, Malkarov MA, Dudnik AP. The Peculiarities of the Early Postoperative Period and the Results of the Treatment in the Patients Presenting with Varicose Veins of the Lower Extremities with the Use of Endovasal Laser Ablation. Flebologiya. 2016;10(4):219–223. (In Russ.) https://doi.org/10.17116/flebo2016104219-223.
14. Chubirko YuM, Kasyanov IО. Combined use of oral and topical forms of phlebotonics after endovascular laser coagulation. Ambulatornaya Khirurgiya. 2024;21(1):42–47. (In Russ.) https://doi.org/10.21518/akh2024-010.
15. Klok FA, Huisman MV. How I assess and manage the risk of bleeding in patients treated for venous thromboembolism. Blood. 2020;135(10):724–734. https://doi.org/10.1182/blood.2019001605.
16. Pavei P, Spreafico G, Bernardi E, Giraldi E, Ferrini M. Favorable long-term results of endovenous laser ablation of great and small saphenous vein incompetence with a 1470-nm laser and radial fiber. J Vasc Surg Venous Lymphat Disord. 2021;9(2):352–360. https://doi.org/10.1016/j.jvsv.2020.06.015.
17. Bogachev VYu, Boldin BV, Turkhin PYu, Jenina OV, Samenkov AYu. Current indications for phlebotropic therapy and its duration. Ambulatornaya Khirurgiya. 2021;18(1):13–23. (In Russ.) https://doi.org/10.21518/1995-1477-2021-18-1-13-23.
18. Li KX, Diendéré G, Galanaud JP, Mahjoub N, Kahn SR. Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review. Res Pract Thromb Haemost. 2021;5(4):e12527. https://doi.org/10.1002/rth2.12527.
19. Bogachev VI, Boldin BV, Turkina PI, Lobanov VN. Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia. Angiology and Vascular Surgery. 2019;25(4):102–107. (In Russ.) https://doi.org/10.33529/ANGIO2019405.
20. Rodnyansky DV, Fokin AA. Diosmin-containing phlebotropic drugs in varicose eczema. Angiology and Vascular Surgery. 2019;25(3):88–92. (In Russ.) https://doi.org/10.33529/ANGI02019303.
21. Burov YuA, Mikulskaya EG, Nesnova ES. The effect of transdermal combined product on the state of microcirculatory blood flow in patients with chronic venous insufficiency. Ambulatornaya Khirurgiya. 2023;20(2):63–68. (In Russ.) https://doi.org/10.21518/akh2023-024.
22. Pozdnyakov DI, Shabanova NB, Gerashchenko AD, Sarkisyan KH. Comparative evaluation of the effectiveness of phlebotonic gels. Ambulatornaya Khirurgiya. 2022;19(2):119–126. (In Russ.) https://doi.org/10.21518/1995-1477-2022-19-2-119-126.
23. Buzlama AV, Verlina AA, Kuznetsov AYu, Alisenko EA. Comparative evaluation of effect of phlebotropic agents on vascular wall permeability in preclinical studies. Ambulatornaya Khirurgiya. 2023;20(2):150–158. (In Russ.) https://doi.org/10.21518/akh2023-042.
Review
For citations:
Senin A.A., Gavrilov V.A., Ablyayev F.K. Heparin, escin and essential phospholipids gel as part of complex therapy in the early postoperative period in patients with lower limb varicose vein disease. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2025;22(1):206-212. (In Russ.) https://doi.org/10.21518/akh2025-026

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.